T Rowe Prices Tony Wang Shifts Focus From Nvidia to AI Bottlenecks and Space Frontier Honeywell Shares Outperform Market on Positive Developments General Motors Expands Electric Lineup with Cadillac Vistiq 300Mile Range Targets Luxury EV Segment Kazatomprom Reports 17 Production Surge in Q3 Signaling Robust Uranium Output EasyJet Reassures Summer Operations Stable Despite Jet Fuel Supply Concerns Amid Iran Tensions BHP Acknowledges Decarbonisation Delay as Western Australian Premier Emphasises Miners Moral Responsibility SOLS Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges EQR Q1 2026 Earnings EPS Falls Short of Estimates by 257 Magyar Bancorp Inc MGYR Q4 2025 Earnings EPS of 040 Reported Shares Edge Lower IKT Q1 2026 Earnings Narrower Loss Beats Estimates Stock Slips on No Revenue Update Sprout Social Inc SPT Q1 2026 Earnings EPS Beats Estimates by Wide Margin EXFY Q1 2026 Earnings EPS Beats Estimates by 68 as Cost Discipline Drives Profitability Calidi Biotherapeutics CLDI Declines Slightly Approaching Key Support at 016 Activate Energy Acquisition Corp Warrant AEAQW Slips 5 Support Test Looms Vista Gold Corp VGZ Holds Near Support at 225 Amid Mild Downtick BHFAL Edges Lower Navigating Support and Resistance in a FixedIncome Landscape Anfield Energy Shares Gain Ground as Uranium Sector Shows Strength Nvidia Stock Approaches Critical Technical Level Traders Eye Potential Breakout or Reversal UZF Q1 2026 Earnings Strong EPS Beat Signals Operational Efficiency Stem Inc STEM Slips 146 Amid Resistance Test Key Support at 96 in Focus PHUN Q1 2026 Earnings EPS Beats Estimates Amid Limited Revenue Disclosure WALD Q4 2024 Earnings EPS Misses Estimates Significantly as Stock Rises Talos Energy Q1 2026 Earnings EPS Beat Drives Positive Market Sentiment SNPS Q1 2026 Earnings Earnings Beat Estimates Stock Rises on Strong Performance ASP Isotopes Q4 2025 Earnings Widerthanexpected loss fails to dampen investor sentiment TVTX Q1 2026 Earnings EPS Misses Estimates as Clinical Costs Weigh on Results Stock Surges 78 Eikon Therapeutics Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline